Cell Culture Media, Sera, and Reagents Market to reach US$7.1 bn by 2023

The global cell culture media, sera, and reagents market has registered impressive growth in recent past. The rising demand for biopharmaceuticals and artificial organs has propelled the global market to a significant extent. In 2014, the global cell culture media, sera, and reagents market stood at US$3.7 bn. Analysts expect the market to expand at a CAGR of 6.70% over the period of 2015-2023 and reach US$7.1 bn by the end of 2023. 

Cell Culture Media: Dominating Global Cell Culture Media, Sera, and Reagents Market

Media, sera, and reagents are the three major components of the global cell culture market. Among these, the market for cell culture media dominates the global cell culture media, sera, and reagents market. At present, the demand for cell culture media has been shifting from serum-based media to serum-sparing media, serum-free animal derived media, and chemically-defined media. The advancement in cell culture and cell productivity has led to the adoption of smaller procedures, employing single use equipment, which in turn, has raised the demand for ready-to-use media powders, and liquid media.

Macromolecules, carrier proteins, fetal bovine, low molecular weight nutrients, newborn calf and adult bovine sera, and hormones are the key products of the sera market. The sera market is expected to witness a sluggish growth on account of the risk of viral contamination associated with the insertion of serum from animal source.

Cell dissociation reagents, cell freezing media, extracellular attachment matrices, cell washing solutions, and amino acids are the most common reagents available across the globe. These reagents are utilized to detect or synthesize another substance, which is under study in the culture. 

Request a Sample Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6598

North America: Leading Regional Market for Cell Culture Media, Sera, and Reagents

On the regional front, the global market for cell culture media, sera and reagents has been distributed among North America (Canada and the U.S.), Europe (the U.K., Germany, and the Rest of Europe), Asia Pacific (China, Japan, Korea, India, and the Rest of Asia Pacific), Latin America (Mexico, Brazil, and the Rest of Latin America), and the Rest of the World (Russia and Israel).

In 2014, the cell culture media, sera and reagents market in North America acquired the leading position, accounting for more than 40% of the overall market. The favorable government policies to encourage life sciences projects and stem cell research contribute to the significant growth of this industry in North America.

On the other hand, the Asia Pacific cell culture media, sera, and regents market is likely to post the fastest growth in the global market over the period from 2015 to 2023. Of late, a rise in the number of market participants in emerging economies of Asia Pacific is evident in the regional market. This trend, coupled with the emerging trend of outsourcing research processes, is expected to boost the market for cell culture media, sera, and regents in this region.

Global Cell Culture Media, Sera, and Reagents Market: Competitive Landscape

The global cell culture media, sera, and reagents market is highly concentrated in nature with a few established players. However, the untapped opportunities presented by emerging economies across the world have encouraged a large number of small cap companies to venture into this market.

Becton, Dickinson and Co., EMD Millipore, Corning Life Sciences B.V., GE Healthcare, PromoCell GmbH, Lonza Group Ltd., Sigma-Aldrich Co. LLC, VWR International LLC, Thermo Fisher Scientific Inc., and Wheaton Industries Inc. are some of the major participants in the global market for cell culture media, sera, and reagents.